NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $313,000 | -71.5% | 120,000 | -82.0% | 0.02% | -78.8% |
Q4 2018 | $1,099,000 | -86.4% | 666,000 | -59.9% | 0.08% | -84.9% |
Q3 2018 | $8,058,000 | -25.0% | 1,661,420 | -3.3% | 0.56% | +1.6% |
Q2 2018 | $10,737,000 | +4.4% | 1,717,983 | +38.7% | 0.55% | +26.5% |
Q1 2018 | $10,284,000 | +8.6% | 1,239,000 | +33.5% | 0.44% | -11.9% |
Q4 2017 | $9,466,000 | +62.7% | 928,000 | +45.9% | 0.50% | +69.6% |
Q3 2017 | $5,818,000 | -5.7% | 635,865 | -24.7% | 0.29% | -12.3% |
Q2 2017 | $6,169,000 | – | 845,000 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |